Clarence Patrick Machado Insider Trading $RCUS Arcus Biosciences, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Clarence Patrick Machado.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Clarence Patrick Machado. Clarence Patrick Machado is Director in MEDIVATION, INC. ($MDVN) and Sr. Vice President and CFO in MEDIVATION, INC. ($MDVN) and Director in CHIMERIX INC ($CMRX) and Director in SCYNEXIS INC ($SCYX) and Director in ENDOCYTE INC ($ECYT) and Director in INOTEK PHARMACEUTICALS CORP ($ITEK) and 10% Owner in Arbutus Biopharma Corp ($TKMR) and Director in Principia Biopharma Inc. ($PRNB) and Director in Adverum Biotechnologies, Inc. ($ADVM) and Director in Turning Point Therapeutics, Inc. ($TPTX) and 10% Owner in Axovant Sciences Ltd. ($AXON) and Director in Axovant Sciences Ltd. ($AXON) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and Director in Arcus Biosciences, Inc. ($RCUS) and 10% Owner in Urovant Sciences Ltd. ($UROV).

Clarence Patrick Machado in Arcus Biosciences, Inc.

Trading Symbol: RCUS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarence Patrick Machado: Director
Holdings: 3,000 shares
Latest Transaction: Jun 08 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Clarence Patrick Machado in Arcus Biosciences, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADVM, TKMR, RCUS, CMRX, ECYT, MDVN, MYOV, PRNB, RCKT, SCYX, AXON, TPTX, UROV

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 08 2020RCUSArcus Biosciences, ...Machado PatrickDirectorOption ExerciseA30.0514,000420,70014,000
Jun 08 2020RCUSArcus Biosciences, ...Machado PatrickDirectorGrantA0.003,00003,0000 to 3 K
Dec 12 2019RCUSArcus Biosciences, ...Machado PatrickDirectorOption ExerciseA8.5550,000427,50050,000

Page:   1